A comparison of the binding sites of antibodies and single-domain antibodies
Antibodies are the largest class of biotherapeutics. However, in recent years, single-domain antibodies have gained traction due to their smaller size and comparable binding affinity. Antibodies (Abs) and single-domain antibodies (sdAbs) differ in the structures of their binding sites: most signific...
Main Authors: | , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2023
|